Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol
Authors
Keywords
-
Journal
BMJ Open
Volume 12, Issue 4, Pages e050264
Publisher
BMJ
Online
2022-05-17
DOI
10.1136/bmjopen-2021-050264
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta-analysis
- (2020) Hui Yang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Associations among statins, preventive care, and prostate cancer mortality
- (2020) Abhishek Kumar et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer
- (2020) Joseph Longo et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy
- (2020) Robert J. Hamilton et al. EUROPEAN UROLOGY
- Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications
- (2019) Maria I. Van Rompay et al. EUROPEAN JOURNAL OF CANCER
- The REDCap consortium: Building an international community of software platform partners
- (2019) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Serum Lipids Prior to Starting Androgen Deprivation Therapy and Risk of Castration-Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database
- (2019) Shweta Dambal et al. JOURNAL OF UROLOGY
- Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy—A Randomized, Double-blind, Placebo-controlled Clinical Trial
- (2018) Teemu J. Murtola et al. EUROPEAN UROLOGY
- Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy
- (2018) Sonja Stieb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- DNA Repair in Prostate Cancer: Biology and Clinical Implications
- (2017) Joaquin Mateo et al. EUROPEAN UROLOGY
- Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer
- (2017) W Han et al. ONCOGENE
- Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers
- (2017) Soudabeh Kavousipour et al. Current Molecular Pharmacology
- Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells
- (2016) Heimo Syvälä et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
- (2016) Rhonda Arthur et al. Cancer Medicine
- Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis
- (2016) Tobias Engel Ayer Botrel et al. PLoS One
- Cholesterol lowering: role in cancer prevention and treatment
- (2015) Toshiyuki Murai BIOLOGICAL CHEMISTRY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer
- (2015) Lauren C. Harshman et al. JAMA Oncology
- Primary Androgen Deprivation Therapy for Prostate Cancer in Koreans: A Retrospective Multicenter Study
- (2015) Won Ik Seo et al. World Journal of Mens Health
- Androgen-regulated metabolism and biosynthesis in prostate cancer
- (2014) Stefan J Barfeld et al. ENDOCRINE-RELATED CANCER
- Long-term efficacy and safety of statin treatment beyond six years: A meta-analysis of randomized controlled trials with extended follow-up
- (2014) Han-lu Lv et al. PHARMACOLOGICAL RESEARCH
- Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
- (2014) Daniel Ackerman et al. TRENDS IN CELL BIOLOGY
- Statins and Protein Prenylation in Cancer Cell Biology and Therapy
- (2012) Carmen Garcia-Ruiz et al. Anti-Cancer Agents in Medicinal Chemistry
- Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial
- (2012) Nicolas Mottet et al. BJU INTERNATIONAL
- The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
- (2012) Teemu J. Murtola et al. PLoS One
- Comparative effects of high and low-dose simvastatin on prostate epithelial cells: The role of LDL
- (2011) Teemu J. Murtola et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lipid accumulation and dendritic cell dysfunction in cancer
- (2010) Donna L Herber et al. NATURE MEDICINE
- Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer
- (2008) Robert W. Ross et al. CANCER
- Clinical biomarkers for hypoxia targeting
- (2008) Quynh-Thu Le et al. CANCER AND METASTASIS REVIEWS
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now